Immunotherapy allogeneic GM-CSF secreting cellular vaccine
Sponsors
Cell Genesys
Conditions
Prostate Cancer
Phase 1
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
CompletedNCT00140348
Start: 2001-12-31End: 2005-04-30Target: 80Updated: 2007-12-24
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer
CompletedNCT00140400
Start: 1999-05-31End: 2001-01-31Target: 50Updated: 2005-09-01
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)
CompletedNCT00140387
Start: 1999-05-31End: 2001-03-31Target: 20Updated: 2005-09-01
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
CompletedNCT00140374
Start: 1998-12-31End: 2001-02-28Target: 36Updated: 2005-09-01